GH1 and melanoma: Furthermore, our study reveals that exosomes obtained from melanoma cells treated with a combination of pegvisomant, GH, and doxorubicin significantly increased the retention of the DiOC2(3) dye and the reduction in IC50 in recipient melanoma cells compared with the recipient cells exposed to exosomes obtained from cells treated with GH or doxorubicin.